Milk Vs Wheat Protein Intake to Maximize Whole-body Protein Synthesis Rates in Healthy Older Adults

NCT ID: NCT06783075

Last Updated: 2025-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-01

Study Completion Date

2027-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dietary protein intake is essential for tissue renewal and growth. Current recommendations for protein intake are based on studies using egg protein as reference protein. Egg protein is an animal-based protein with a high quality. Protein quality is determined by the composition of (essential) amino acids and digestibility. Therefore, different proteins have a different quality. Due to the environmental crisis, an increasing number of people consumes more plant-based proteins. These plant-based proteins often have a lower protein quality compared to animal-based proteins. Therefore, the aim of this study is to investigate whether optimal protein intake depend on protein quality. The optimal protein intake of an animal-based protein with a high quality (milk) will be compared to the optimal protein intake of a plant-based protein with a low quality (wheat).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Protein Metabolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Double-blind, randomized, parallel study design
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Protein beverages with milk- or wheat composition will look similar.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MILK

Drink containing amino acid composition of milk protein

Group Type ACTIVE_COMPARATOR

MILK

Intervention Type OTHER

Drink containing amino acids in the composition of milk protein

WHEAT

Drink containing amino acid composition of wheat protein

Group Type ACTIVE_COMPARATOR

WHEAT

Intervention Type OTHER

Drink containing amino acids in the composition of wheat protein

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MILK

Drink containing amino acids in the composition of milk protein

Intervention Type OTHER

WHEAT

Drink containing amino acids in the composition of wheat protein

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 65-85 years
* BMI between 18.5-30 kg\*m\^-2
* Healthy, recreationally active (maximal one intensive exercise training per week)
* No physical limitations (i.e., able to perform all activities associated with daily living independently)

Exclusion Criteria

* Smoking
* Diagnosed musculoskeletal disorders
* Use of any medications known to affect protein metabolism (i.e., corticosteriods, non-steroidal anti-inflammatories)
* Chronic use of gastic acid-suppressing medication or anti-coagulants
* Unstable weight over the last 3 months
* Diagnosed GI tract disorders or diseases
* Blood donation in the past 2 months
Minimum Eligible Age

65 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maastricht University Medical Center+

Maastricht, Limburg, Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Luc van Loon

Role: CONTACT

0031 43 388 1743

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Loïs Reijnders

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

METC 24-051

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Protein Supply in Elderly
NCT01317511 COMPLETED NA
Milk and Plant Protein Digestion
NCT06272331 COMPLETED NA